Download important dates what you can't afford to miss

WHAT YOU CAN’T
AFFORD TO MISS
The AACR Annual Meeting covers the full spectrum of cancer
research—including basic, translational, clinical, and population
research—through a variety of session formats. You will join more
than 18,000 fellow attendees, be among the best and brightest
researchers and clinicians in cancer research, and have the
opportunity to network and form collaborations with colleagues from
more than 70 countries. As an Annual Meeting attendee, you will have
IMPORTANT DATES
January 20, 2015
Membership Application Deadline for Prospective Late-Breaking
Abstract Sponsors
Regular Abstract Status Notifications Sent
February 2, 2015
Late-Breaking Abstract Submission Deadline
January 27, 2015
Membership Application Deadline for Advance Registration Rate
Clinical Trials Placeholder Abstracts – Final Results
and Conclusions Deadline
February 27, 2015
Online Itinerary Planner Available
February 19, 2015
Advance Registration Deadline
February 9, 2015
Late-Breaking Abstract Status Notifications Sent
• A full day of Educational Sessions and Methods Workshops
Housing Reservation Deadline
access to:
• Four Plenary Sessions of important general interest
• A new Wrap-Up Plenary Session on Wednesday, April 22, featuring key
opinion leaders presenting highlights from the meeting and their vision of
future trends in cancer research
March 4, 2015
March 6, 2015
Cancellation Deadline for Registration Refunds
(less $75 processing fee)
Onsite Registration Opens (Pennsylvania Convention Center)
April 17, 2015
Regular Abstract Bodies Posted to Online Itinerary Planner
March 18, 2015
Late-Breaking Abstract Bodies Posted to Online Itinerary
Planner
• Over three dozen Major Symposia
• Over two dozen Recent Advances in Organ Site Research, Diagnostics and
Therapeutics Research, and Epidemiology and Prevention Research Sessions
April 18, 2015
Annual Meeting Begins
• Minisymposia featuring short talks from highly rated proffered abstracts
Annual Meeting 2015
Program Guide App
• Thousands of posters highlighting the latest discoveries in cancer research
• Opportunities for networking and professional development
Carry the Annual Meeting with
you wherever you go—with or
• Over 50 Meet-the-Expert Sessions, where attendees can hear from
renowned researchers on specialized topics
without a network connection.
The Program Guide App is
• Twelve Forums in which scientific leaders debate controversial subjects in
cancer research
available in native versions to
serve users of iPhone, iPad,
and Android devices and
also in a browser-based
version for use on most webenabled smartphones and tablets. Available in
Visit www.AACR.org/Program2015 to view the full list of exciting
sessions at the AACR Annual Meeting 2015.
late March 2015.
Follow us on
Visit www.AACR.org/Program2015
to view the full list of exciting sessions at
the AACR Annual Meeting 2015.
DONATE
Continuing Medical Education ActivityAMA PRA Category 1 CreditsTM Available
January 27, 2015
Late-Breaking and Placeholder
Abstract Submission Deadline:
615 Chestnut Street | 17th Floor
Philadelphia, PA 19106
Email: [email protected]
Telephone: 215-440-9300
Toll-free Telephone: 866-423-3965
April 18-22, 2015 • Pennsylvania Convention Center • Philadelphia, PA • www.AACR.org • #AACR15
See inside for details!
• Clinical Trials Symposia
• Minisymposia
• Poster Sessions
Clinical Trials featured in:
We look forward
to seeing you in
Philadelphia, PA,
AACR’s home
town!
Submission Deadline: January 27, 2015
Continuing Medical Education ActivityAMA PRA Category 1 Credits™ available
LATE-BREAKING AND
PLACEHOLDER ABSTRACTS
AACR ANNUAL MEETING 2015 Late-Breaking Abstracts and Clinical Trials
Submit your late-breaking abstracts
Clinical Trials Presentations
The deadline for late-breaking abstracts is January 27, 2015 and is an
opportunity to submit results that were not available at the time of
the regular abstract deadline. Abstracts detailing highly significant
and timely findings in any area of cancer research may be submitted
to one of ten late-breaking abstract submission categories. A special
subcommittee of the Program Committee will evaluate the merit of
late-breaking abstracts. Only those abstracts that are deemed to be
of high scientific priority will be accepted for presentation at the
Annual Meeting. Select highly rated abstracts may be chosen for oral
presentation in minisymposia.
Submit your phase I, II, III, or combination clinical trials abstracts,
from national or international clinical trials, to the Clinical Trials
categories (CT01-CT08) by the late-breaking abstract deadline of
January 27, 2015.
• Every abstract is considered for one of the 38 oral presentation
opportunities.
• Four Clinical Trials Symposia offer companion presentations
explaining the science behind the presented trials.
• All stakeholders, including members of industry, are eligible to
present their work.
Please visit www.AACR.org/LBA15 for details on the abstract
submission process.
Data not ready yet?
Submit a placeholder abstract to the appropriate PL category.
Are you interested in sponsoring a late-breaking
or placeholder abstract, but you haven’t become
an AACR member yet?
Visit www.AACR.org/CT15 for instructions on abstract submission.
Clinical Trials in Progress Poster Session
Become an AACR member today and enjoy the privilege of
sponsoring abstracts for AACR Annual Meetings. To sponsor a
late-breaking or placeholder abstract, be sure to submit your
membership application by January 20, 2015.
Late-breaking abstracts submitted to the Clinical Trials in Progress
(CT08) category should summarize promising ongoing trials that have
not yet yielded results. A separate poster session will be dedicated to
the presentation of abstracts accepted to this category.
Visit www.AACR.org/Benefits to learn more about the benefits of
AACR membership such as reduced registration rates for
conferences, discounts on the AACR’s publications, eligibility to join
the association’s special interest groups, and more.
Please visit www.AACR.org/CT15 for additional information.
Clinical Trials
Placeholder Abstracts
If you anticipate obtaining final
results of your trial after the latebreaking deadline, submit a
placeholder abstract containing
your preliminary data to the
appropriate Placeholder category
(PL01-PL07) by January 27, 2015.
Completed abstracts, including all
final data and analyses, must be
submitted by February 27, 2015.
What qualifies as a
late-breaking abstract?
An abstract that details highly
significant and timely findings
in any area of cancer research
that were not available at the
time of the December 3 regular
abstract deadline.
Visit www.AACR.org/Program2015 to view the full list of exciting sessions at the AACR Annual Meeting 2015.
PROGRAM HIGHLIGHTS
April 18-22, 2015 • Pennsylvania Convention Center • Philadelphia, PA
On Saturday, April 18, 2015, a full program of Educational Sessions, Methods Workshops, Meet-the-Expert Sessions, and
Award Lectures will be presented beginning at 8:00 a.m. The Opening Ceremony and the Opening Plenary Session will
take place on Sunday morning, April 19. The meeting will conclude at 1:30 p.m. on Wednesday, April 22.
The 2015 Program in Progress follows.
Plenary Sessions
Stem Cells and Cancer Cell of Origin
Value-Based Drug Development
SUNDAY, APRIL 19
Targeted Therapies in Hematologic Malignancies
What Comes First? Is Deregulation the Chicken or the Egg?
Opening Plenary Session: The Genome and Beyond
Targeting Macromolecular Signaling Complexes
What Is the Real Target of Bromodomain Inhibitors?
Chairperson: Lewis C. Cantley
Targeting MYC
Speakers: Michael R. Stratton, Stephen B. Baylin, Tyler Jacks,
and Robert D. Schreiber
Targeting Pathway Rewiring to Improve Cancer Therapy
Regulatory Symposia
Tumor Heterogeneity: Targets and Mechanisms
Clinical Trial Strategies
Additional speaker to be announced
Tumor Microenvironment
Immunotherapies
The Tumor Proteome as a Guide for Precision Medicine
Laboratory-Developed Tests
Minimal Residual Disease
Precision Medicine Comes to Cancer Prevention and Screening
Recent Advances in Organ Site
Research Sessions
Chairperson: Andrew J. Dannenberg
Barrett’s Esophagus: Models, Genomics, and Genetics
NGS-Based Onco-Panels
Speakers: Andrew T. Chan, Douglas R. Lowy, David A. Ahlquist,
and Anna Mae E. Diehl
Colorectal Cancer Subtypes
Patient-Reported Outcomes
Elucidating Mechanisms that Underlie the Development of
Pediatric Brain Cancers
Regulatory Strategies
MONDAY, APRIL 20
TUESDAY, APRIL 21
Drug Resistance
Chairperson: Bert Vogelstein
Speakers: Bert Vogelstein, Alan Ashworth, Alice T. Shaw, and
Joan S. Brugge
Heterogeneity and Microenvironment: Drivers of
Breast Cancer Evolution
Localized Prostate Cancer: Next-Generation Signaling
and Beyond
Metastatic Prostate Cancer Precision Medicine:
Challenges and Solutions
Neoadjuvant Treatment
Tyrosine Kinase Inhibitors
Science Policy Sessions
International Patient Advocacy
NIH-NCI Funding
Tobacco and E-Cigarettes
WEDNESDAY, APRIL 22
MicroRNAs and Noncoding RNAs in the Pathogenesis of
Liver Cancer and Therapeutic Implications
Value-Based Drug Development Forum
Oncology Meets Immunology: Not Just Another "Hallmark"
Modeling Human Sarcomas
Chairperson: Robert H. Vonderheide
Multimodality Prostate Cancer Imaging
Educational Sessions and
Methods Workshops
Speakers: Glenn Dranoff, Lisa M. Coussens, Elizabeth M. Jaffee,
and Ira Mellman
New Insights in Estrogen Receptor Biology and Implications
for Treatment
WEDNESDAY, April 22
New Insights into the Role of Ultraviolet Radiation
in Melanoma
NEW Wrap-Up Plenary Session
AACR Annual Meeting 2015: Latest Developments,
Future Trends
Basic Science: Lewis C. Cantley
Clinical and Translational Science: Carlos L. Arteaga
Prevention and Early Detection: William G. Nelson
Wrap-Up and Vision for the Future
The New Landscape of Epigenetic Therapy for
Lymphoid Malignancies
Pancreatic Cancer in 2015: An Integrated View of a
Complex Disease
Pancreatic Cancer: The Promise and Pitfalls of Targeting
the Stroma
Progress in Understanding Small Cell Lung Cancer
Recent Advances in Skin Development and Skin Cancers
Major Symposia
Translational Advances in Brain Cancer
Adoptive T-Cell Therapy
What Does Stem Cell Reprogramming Teach Us about
Hematologic Malignancies?
A full day of educational programming will take place on
Saturday, April 18. Educational Sessions provide broad, stateof-the-art overviews of important areas in the field and will
benefit individuals who want to learn more about an area in
which they are not expert. During Methods Workshops,
investigators carefully describe laboratory techniques and their
potential for cancer research such that participants can
determine how to apply the techniques to their own research.
Over 50 sessions on topics such as big data, models of cancer,
precision radiotherapy, and the tumor microenvironment will
comprise the educational program. The “From Chemistry to
the Clinic: Pathways for Drug Development” series and the
popular “Tumor Immunology for the Non-Immunologist”
session will once again be offered. The program will also
feature sessions on Regulatory Science with speakers
from the U.S. Food and Drug Administration. Visit
www.AACR.org/Program2015 to view the latest updates.
Aging and Senescence
Antiangiogenesis Revisited
Applying Systems Biology in the Oncology Clinic
Autophagy and Cancer
Cancer, Type 2 Diabetes, and Cardiovascular Disease:
Comparison of Risk Factors
Cell Death and Cancer Therapy: Why Has Conventional
Chemotherapy Been So Successful?
Cellular Reprogramming in Carcinogenesis: Implications for
Tumor Heterogeneity, Prognosis, and Therapy
Challenges in Mutation Detection
Recent Advances in Diagnostics and
Therapeutics Research Sessions
Ablation of Oligometastases during Systemic Therapy
Biomarkers for Immunotherapy Response
Biomarkers of Antiangiogenic Therapy: Are We Lost
in Translation?
Clinical Applications of Liquid Biopsy: Current Status and
Future Developments
Dose Optimization for 21st Century Oncology Drugs
DNA Repair Deficiencies
Meet-the-Expert Sessions
Sixty Meet-the-Expert Sessions will be held throughout the
meeting. During these sessions, leaders in the field provide a
synthesis of recent research advances and engage audience
members in discussion. A list of experts and their topics will be
added to the online program as they are available. Visit
www.AACR.org/Program2015.
Professional and Career
Advancement Sessions
Genomic Investigations in Childhood Cancer
10th Annual Undergraduate Student Caucus and
Poster Competition
Germline Alterations and Susceptibility to Childhood Cancer
18th Annual Grant Writing Workshop
Metabolism and Adaptive Immune Responses
Cancer and Biomedical Research Career Fair
New Strategies in Theranostics
Career Conversations
Deregulation of Cancer Hallmarks by microRNAs and other
Noncoding RNAs
Novel Delivery Systems and/or Formulations in
Cancer Treatment
Careers in the Biotechnology and Pharmaceutical Industries
Diverse Approaches for Targeting RAS-Driven Cancers
Phenotypic Screening for Optimizing Cancer Therapy
Careers in Clinical and Translational Cancer
Research Roundtable
Empowering Antibodies to Fight Cancer: ADCs and
Immunoconjugates
Predictive Biomarkers of DNA Repair
Effective Communication with Peers and the Public
Enhancing Efficacy of Cancer Immunotherapy by Use of
Ablative Therapy
Recent Advances in Epidemiology and
Prevention Research Sessions
Meet the Research Icon
Breast Cancer around the World: Is It the Same Disease?
Networking Hubs
Cancer Risk Factors and Targeted Screening
Personalized Career Discussions
Early Detection/Overdiagnosis
Science Reproducibility: Proper Management and Publication
of Data
Chemical Probes for Use in Cancer Research
Chromatin and Senescence
Chronic Infections Driving Cancer
Computational Approaches to Cancer Target and
Drug Discovery
Epigenetic Mechanisms in Cancer Risk
Gene Expression Programs Underlying the Stem Cell State
How to Combine Targeted Therapy with Immunotherapy
Imaging of Immunotherapy in Action
In Vivo Modeling of the Noncoding RNA Revolution
in Cancer
Innate and Adaptive Immunity in Cancer
Interpreting the Cancer Genome in the Clinic
Intraoperative Imaging
Liquid Biopsy Approaches for Detecting, Monitoring, and
Characterizing Human Cancer
Mechanisms of Resistance: From Signaling Pathways to
Stem Cells
Mechanisms of Tumor Immune Escape
Metabolism and Aging
Microbiome and Tumor Immunity
Nucleotide Metabolism in Cancer Cell Growth and Survival
Obesity, Energy Balance, and Cancer
Oncometabolites
Meet the Mentor: Undergraduate Focus
Epidemiology of Obesity and Endometrial Cancer
Immunoprevention
Lung Cancer and COPD: Commonalities
Navigating the Road to a Successful Career in Cancer Research
Special Program for High School Students: The Conquest of
Cancer and the Next Generation of Cancer Researchers
WICR Professional Advancement Session
Forums
Are Cancer Stem Cells Relevant to the Success of Human
Cancer Therapy?
Avatar Mouse Models for Personalized Cancer Treatment
Bridging the Gap between Academia and Industry in
Drug Discovery
Challenges in Trial Design for the Genomic Era
Controversies in RAS Signaling: Wild Type RAS—Tumor
Suppressor or Partner in Tumorigenesis?
Dietary Supplements and Cancer Risk and Prognosis
Is MET Still a Relevant Target in Lung Cancer?
Pan-Cancer Analysis of Whole Genomes
Opportunities and Challenges in the Use of Animal Models for
Cancer Target Validation and Drug Development
Proteogenomics and Phosphoproteomics in Cancer: Analysis
of the TCGA Tumor Samples
Role of Autophagy in Cancer Development,
Progression, and Therapy
AACRcentral
At the crossroads of the Exhibit Hall,
AACRcentral is your one-stop source for
information on and assistance with all
AACR programs. Whether you need to ask
a question, find a job, check your email, or
meet up with a colleague, make
AACRcentral the starting point when you
tour the exhibits.
The program is subject to change. Please visit www.AACR.org/Program2015 for the latest details.